Why consider treatment in China for Bone Marrow Transplant (HSCT)?

China offers advanced HSCT technology at significantly lower costs compared to Western countries, often saving 50–70%. Major transplant centers in Beijing, Shanghai, and Guangzhou have extensive experience with haploidentical transplants, achieving outcomes comparable to international standards. Many hospitals are JCI-accredited and staffed by English-speaking specialists trained abroad. The combination of high-volume expertise, modern facilities, and cost efficiency makes China a compelling option for international patients.